The introduction of nicotinamide for a nicotine replacement in e-cigarette and smokeless products represents an important regulatory challenge for your FDA. Nicotinamide does not have nicotinic receptor agonist action and is known to act as a sedative at high dosages6. The promises created by Nicotine River, ECBlend, and also other distributors tha… Read More